Peers of CRISPR Therapeutics AG (CRSP)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by free cash flow over the last 12 months. Values the whole business on the cash it generates.
Latest EV/FCF
-8.18x
As of Oct 22, 2026
Beyond EV/FCF, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/FCF |
|---|---|
| Oct 22, 2026 | -8.18x |
| Oct 21, 2026 | -8.30x |
| Oct 20, 2026 | -8.14x |
| Oct 19, 2026 | -8.18x |
| Oct 16, 2026 | -7.98x |
| Oct 15, 2026 | -8.57x |
| Oct 14, 2026 | -8.23x |
| Oct 13, 2026 | -8.20x |
EV/FCF = Enterprise Value / Free Cash Flow (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/FCF is especially insightful for capital-intensive businesses.
Read the general EV/FCF definition, formula, and analyst usage guide.
EV/FCF guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison